Herbasana cultivates and manages an integrated supply chain for medical cannabis, ensuring high-quality, affordable products for German patients. By overseeing cultivation in Colombia and adhering to rigorous testing, the company provides a consistent supply of medical cannabis through the established pharmacy fulfillment pathway.
Funding
Funding not disclosed
Founders
Product
Problem
Patients in Germany seeking medical cannabis often face challenges in accessing high-quality, affordable products. The current market can be fragmented, making it difficult for patients to find reliable sources and understand the therapeutic options available.
Solution
Herbasana facilitates patient access to medical cannabis by managing an integrated supply chain from cultivation to finished product. The company cultivates cannabis in Colombia, leveraging optimal environmental conditions and rigorous agronomic testing to ensure product quality. Herbasana's model aims to provide German patients with a consistent supply of affordable medical cannabis. The process involves patients consulting with physicians, obtaining prescriptions, and then filling them at pharmacies, with Herbasana supporting this pathway by ensuring product availability.
Target Audience
The primary target audience includes patients in Germany who have been prescribed medical cannabis and physicians who recommend it as a therapeutic option.
Features
- Cultivation of medical cannabis in Colombia, utilizing favorable climate and soil conditions.
- Integrated supply chain management, overseeing operations from seed to finished product.
- Agronomic testing and quality control protocols applied throughout the cultivation process.
- Focus on providing affordable medical cannabis products to the German market.
- Facilitation of patient access through a prescription and pharmacy fulfillment model.